J&J to pay $263 million to settle opioid charges

Saturday, 26. June 2021 19:36

Johnson & Johnson will pay $263 million over a period of nine years to resolve claims that the company helped create the opioid crisis in New York.

According to the terms of the agreement, the pharmaceutical giant will, alongside all of its subsidiaries and successors, stop manufacturing or selling opioids in the state. However, J&J did not admit liability or wrongdoing.

"The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids. Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business - not only in New York, but across the entire country," Attorney General Letitia James said in the announcement.

Related Links: Johnson & Johnson
Breaking the News / MD